日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study

一种优化的长效生长抑素类似物用于转移性神经内分泌肿瘤肽受体放射性核素治疗的安全性、剂量学和疗效：从临床前试验到首次人体试验

期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2024.05.022
Guo, Wei; Wen, Xuejun; Chen, Yuhang; Zhao, Tianzhi; Liu, Jia; Tao, Yucen; Fu, Hao; Wang, Hongjian; Xu, Weizhi; Pang, Yizhen; Zhao, Liang; Huang, Jingxiong; Xu, Pengfei; Guo, Zhide; Miao, Weibing; Zhang, Jingjing; Chen, Xiaoyuan; Chen, Haojun
信号转导
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Augmentation of bone formation by sympathectomy in rats as evaluated by [(99m)Tc]Tc-MDP.

通过 [(99m)Tc]Tc-MDP 评估交感神经切除术对大鼠骨形成的影响

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1580230
Cai Zili, Lin Xiuting, Zhuang Yuehong, Miao Weibing, Xie Yun
神经科学
发表日期：2025
文献求助 收藏

Reduced splenic uptake of [(68)Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma

一线化疗后脾脏对[(68)Ga]Ga-Pentixafor的摄取减少与新诊断的多发性骨髓瘤患者预后不良相关。

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-025-01262-2
Pan, Qingqing; Chen, Zhenying; Liu, Silu; Zhang, Hongzhe; Feng, Jie; Miao, Weibing; Li, Fang; Cao, Xinxin; Luo, Yaping
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

(68)Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

(68)Ga标记的成纤维细胞活化蛋白抑制剂PET/CT用于预测乳腺癌患者新辅助化疗的早期和晚期病理反应：一项前瞻性研究

期刊:
影响因子:
doi:10.2967/jnumed.123.266079
Chen, Ling; Zheng, Shan; Chen, Linying; Xu, Sunwang; Wu, Kunlin; Kong, Lingjun; Xue, Jiajie; Chen, Xiangjin; Miao, Weibing; Zhu, Youzhi
成纤维细胞
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2023
文献求助 收藏

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial

阿帕替尼与安慰剂治疗局部晚期或转移性、放射性碘难治性分化型甲状腺癌患者：REALITY随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2021.6268
Lin, Yansong; Qin, Shukui; Li, Zhiyong; Yang, Hui; Fu, Wei; Li, Shaohua; Chen, Wenxin; Gao, Zairong; Miao, Weibing; Xu, Huiqin; Zhang, Qing; Zhao, Xinming; Bao, Jiandong; Li, Linfa; Ren, Yuan; Lin, Chenghe; Jing, Shanghua; Ma, Qingjie; Liang, Jun; Chen, Guang; Zhang, Hong; Zhang, Yifan; Zhou, Xianfeng; Sang, Yaxiong; Hou, Zhiguo
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD

双靶向PET示踪剂[(68)Ga]Ga-FAPI-RGD的合成、临床前评价和辐射剂量测定

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.79144
Zang, Jie; Wen, Xuejun; Lin, Rong; Zeng, Xinying; Wang, Chao; Shi, Mengqi; Zeng, Xueyuan; Zhang, Jiaying; Wu, Xiaoming; Zhang, Xianzhong; Miao, Weibing; Xu, Pengfei; Guo, Zhide; Zhang, Jingjing; Chen, Xiaoyuan
FAP
发表日期：2022
文献求助 收藏

Evaluation of (99m)Tc-3PRGD(2) integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with (18)F-FDG metabolic imaging

对荷瘤小鼠（肝细胞癌）中 (99m)Tc-3PRGD(2) 整合素受体显像的评价：与 (18)F-FDG 代谢显像的比较

期刊:Annals of Nuclear Medicine
影响因子:2.5
doi:10.1007/s12149-017-1173-4
Zheng, Jieling; Miao, Weibing; Huang, Chao; Lin, Haoxue
肿瘤
肿瘤免疫
信号转导
代谢
细胞生物学
发表日期：2017
文献求助 收藏